Reiter A: Diagnosis and treatment of childhood non-Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007, 1: 285–296.
Article
Google Scholar
Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, Gaulard P, Garderet L, Lepage E, Reyes F, Meignan M: [18
F]fluoro-2-deoxy- D -glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood 2005, 106: 1376–1381. 10.1182/blood-2005-01-0272
Article
CAS
Google Scholar
Safar V, Dupuis J, Itti E, Jardin F, Fruchart C, Bardet S, Véra P, Copie-Bergman C, Rahmouni A, Tilly H, Meignan M, Haioun C: Interim [18
F]fluorodeoxyglucose positron emission tomography scan in diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy plus rituximab. J Clin Oncol 2012, 30: 184–190. 10.1200/JCO.2011.38.2648
Article
CAS
Google Scholar
Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H: Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 2007, 34: 5435–5441.
Article
Google Scholar
Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S, Kobe C, Denecke T, Stöver B, Hautzel H, Henze G, Hundsdoerfer P: Early and late therapy response assessment with [18
F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin's lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 2009, 27: 4385–4391. 10.1200/JCO.2008.19.7814
Article
Google Scholar
Oschlies I, Burkhardt B, Chassagne-Clement C, D'Amore ES, Hansson U, Hebeda K, Mc Carthy K, Kodet R, Maldyk J, Müllauer L, Porwit A, Schmatz AI, Tinguely M, Abramov D, Wotherspoon A, Zimmermann M, Reiter A, Klapper W: Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol 2011, 35: 836–844. 10.1097/PAS.0b013e318213e90e
Article
Google Scholar
Seidemann K, Tiemann M, Schrappe M, Yakisan E, Simonitsch I, Janka-Schaub G, Dörffel W, Zimmermann M, Mann G, Gadner H, Parwaresch R, Riehm H, Reiter A: Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 2001, 97: 3699–3706. 10.1182/blood.V97.12.3699
Article
CAS
Google Scholar
Woessmann W, Seidemann K, Mann G, Zimmermann M, Burkhardt B, Oschlies I, Ludwig WD, Klingebiel T, Graf N, Gruhn B, Juergens H, Niggli F, Parwaresch R, Gadner H, Riehm H, Schrappe M, Reiter A, BFM Group: The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95. Blood 2005, 105: 948–958.
Article
CAS
Google Scholar
Woessmann W, Zimmermann M, Lenhard M, Burkhardt B, Rossig C, Kremens B, Lang P, Attarbaschi A, Mann G, Oschlies I, Klapper W, Reiter A: Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 2011, 29: 3065–3071. 10.1200/JCO.2011.34.8417
Article
Google Scholar
Furth C, Denecke T, Steffen I, Ruf J, Voelker T, Misch D, Vondran F, Plotkin M, Stöver B, Henze G, Lemke AJ, Amthauer H: Correlative imaging strategies implementing CT, MRI, and PET for staging of childhood Hodgkin disease. J Pediatr Hematol Oncol 2006, 28: 501–512. 10.1097/01.mph.0000212962.68007.12
Article
Google Scholar
Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, Lister TA, Vose J, Grillo-López A, Hagenbeek A, Cabanillas F, Klippensten D, Hiddemann W, Castellino R, Harris NL, Armitage JO, Carter W, Hoppe R, Canellos GP: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999, 18: 1244.
Google Scholar
Piepsz A, Hahn K, Roca I, Ciofetta G, Toth G, Gordon I, Kolinska J, Gwidlet J: A radiopharmaceuticals schedule f or imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine. Eur J Nucl Med 1990, 17: 127–129.
Article
CAS
Google Scholar
Boellaard R, O'Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J, Marsden PK, Tatsch K, Hoekstra CJ, Visser EP, Arends B, Verzijlbergen FJ, Zijlstra JM, Comans EF, Lammertsma AA, Paans AM, Willemsen AT, Beyer T, Bockisch A, Schaefer-Prokop C, Delbeke D, Baum RP, Chiti A, Krause BJ: FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010, 37: 181–200. 10.1007/s00259-009-1297-4
Article
Google Scholar
Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD, Imaging Subcommittee of International Harmonization Project in Lymphoma: Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007, 25: 571–578. 10.1200/JCO.2006.08.2305
Article
Google Scholar
Bennett BM: On comparisons of sensitivity, specificity and predictive value of a number of diagnostic procedures. Biometrics 1972, 28: 793–800. 10.2307/2528763
Article
CAS
Google Scholar
Horning SJ, Juweid ME, Schöder H, Wiseman G, McMillan A, Swinnen LJ, Advani R, Gascoyne R, Quon A: Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood 2010, 115: 775–777. 10.1182/blood-2009-08-234351
Article
CAS
Google Scholar
Cox MC, Ambrogi V, Lanni V, Cavalieri E, Pelliccia S, Scopinaro F, Monarca B, Marchetti P, Spiriti MA: Use of interim [18
F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy. Leuk Lymphoma 2012, 53: 263–269. 10.3109/10428194.2011.614704
Article
CAS
Google Scholar
Casasnovas RO, Meignan M, Berriolo-Riedinger A, Itti E, Huglo D, Haioun C, Morschhauser F: Early interim PET scans in diffuse large B-cell lymphoma: can there be consensus about standardized reporting, and can PET scans guide therapy choices? Curr Hematol Malig Rep 2012, 7: 193–199. 10.1007/s11899-012-0129-y
Article
Google Scholar
Moskowitz CH, Schöder H, Teruya-Feldstein J, Sima C, Iasonos A, Portlock CS, Straus D, Noy A, Palomba ML, O'Connor OA, Horwitz S, Weaver SA, Meikle JL, Filippa DA, Caravelli JF, Hamlin PA, Zelenetz AD: Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma. J Clin Oncol 2010, 28: 1896–1903. 10.1200/JCO.2009.26.5942
Article
CAS
Google Scholar
Meignan M, Gallamini A, Haioun C: Report on the first international workshop on interim-PET scan in lymphoma. Leuk Lymphoma 2009, 50: 1257–1260. 10.1080/10428190903040048
Article
Google Scholar
Furth C, Erdrich AS, Steffen IG, Ruf J, Stiebler M, Kahraman D, Kobe C, Schönberger S, Grandt R, Hundsdoerfer P, Hauptmann K, Amthauer H, Hautzel H: Interim PET response criteria in paediatric non-Hodgkin's lymphoma. Results from a retrospective multicenter reading. Nuklearmedizin 2013, 52: 148–156. 10.3413/Nukmed-0546-12-12
Article
CAS
Google Scholar
Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C, Vera P, Bologna S, Brière J, Jais JP, Haioun C, Coiffier B, Morschhauser F, Groupe d'Étude des Lymphomes de l'Adulte (GELA): SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood 2011, 118: 37–43. 10.1182/blood-2010-12-327767
Article
CAS
Google Scholar
Edeline V, Bonardel G, Brisse H, Foehrenbach H, Pacquement H, Maszelin P, Gaillard JF, Michon J, Neuenschwander S: Prospective study of 18
F-FDG PET in pediatric mediastinal lymphoma: a single center experience. Leuk Lymphoma 2007, 48: 823–826. 10.1080/10428190601162854
Article
Google Scholar
Depas G, De Barsy C, Jerusalem G, Hoyoux C, Dresse MF, Fassotte MF, Paquet N, Foidart J, Rigo P, Hustinx R: 18
F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 2005, 32: 31–38. 10.1007/s00259-004-1604-z
Article
Google Scholar
Mody RJ, Bui C, Hutchinson RJ, Frey KA, Shulkin BL: Comparison of (18)F fluorodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma. Leuk Lymphoma 2007, 48: 699–707. 10.1080/10428190601179783
Article
CAS
Google Scholar
Bakhshi S, Radhakrishnan V, Sharma P, Kumar R, Thulkar S, Vishnubhatla S, Dhawan D, Malhotra A: Pediatric nonlymphomblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation—a prospective study. Radiology 2012, 262: 956–968. 10.1148/radiol.11110936
Article
Google Scholar
Hollinger EF, Alibazoglu H, Ali A, Green A, Lamonica G: Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging. Clin Nucl Med 1998, 23: 93–98. 10.1097/00003072-199802000-00007
Article
CAS
Google Scholar
De Gaetano AM, Calcagni ML, Rufini V, Valentini AL, Gui B, Giordano A, Bonomo L: Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls. Abdom Imaging 2009, 34: 696–711. 10.1007/s00261-008-9457-8
Article
Google Scholar
Kashyap R, Lau E, George A, Seymour JF, Lade S, Hicks RJ, Hofman MS: High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2013, 40: 1330–1336. 10.1007/s00259-013-2429-4
Article
Google Scholar
Spaepen K, Stroobants S, Dupont P, Bormans G, Balzarini J, Verhoef G, Mortelmans L, Vandenberghe P, De Wolf-Peeters C: [18
F]FDG PET monitoring of tumour response to chemotherapy: does [18
F]FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging 2003, 30: 682–688. 10.1007/s00259-003-1120-6
Article
CAS
Google Scholar